Poirier M C, Hunt J M, True B A, Laishes B A, Young J F, Beland F A
Carcinogenesis. 1984 Dec;5(12):1591-6. doi: 10.1093/carcin/5.12.1591.
Male Wistar-Furth rats were fed 0.02% 2-acetylaminofluorene (AAF) for 3 days or 0.02% AAF for 25 days followed by 0.02% [ring-3H]AAF for an additional 3 days. The concentration of hepatic DNA adducts was then monitored by both radioimmunoassay and radiolabeling during 28 days of control diet. This approach allowed comparisons to be made of adduct accumulation, removal and persistence at both the beginning and end of a four week carcinogen feeding period. DNA adduct formation remained constant during the month of AAF administration with an accumulation rate of 157 fmol adduct/micrograms DNA during days 1-3 and days 25-28 of the experiment. Furthermore, the rate of removal of adducts formed during these three day periods was similar when both groups were fed control diets for 28 additional days. Continued AAF administration resulted in a slow accumulation of persistent adducts; thus, 91 +/- 6% of the adducts detected after 3 days of AAF feeding were removed during a subsequent month of control diet, while only 65 +/- 11% of the adducts detected after 28 days of AAF diet were removed when rats were fed control diet for an additional 28 days. In a second experiment, the removal of adducts was compared in animals fed control or AAF diet after previously being fed 0.02% AAF for 17 days. Similar removal curves were observed in both groups; therefore, continued ingestion of AAF did not affect the rate of adduct removal. In both experiments, biphasic repair curves were observed. These data were used to develop a pharmacokinetic model. Two genomic regions were postulated, an area susceptible to fast repair and a region more resistant to the removal of AAF adducts. At equilibrium, which was reached after 2-3 weeks of AAF feeding, the concentration of adducts in each region was similar with approximately 150 fmol adduct/micrograms DNA. Although the total number of adducts formed in the fast repair region during one month of AAF administration was five times greater than in the resistant region, the model predicted that the adducts localized in regions resistant to repair were the persistent adducts detected after one month of control diet. Overall, the removal of adducts formed during chronic AAF feeding was very efficient since greater than 93% of the adducts were removed by the end of a subsequent month of control diet.
将雄性Wistar - Furth大鼠喂养含0.02% 2 - 乙酰氨基芴(AAF)的饲料3天,或喂养含0.02% AAF的饲料25天,随后再喂养含0.02% [环 - 3H]AAF的饲料3天。然后在28天的对照饮食期间,通过放射免疫测定和放射性标记监测肝脏DNA加合物的浓度。这种方法使得能够比较在四周致癌物喂养期开始和结束时加合物的积累、清除和持久性。在AAF给药的一个月内,DNA加合物的形成保持恒定,在实验的第1 - 3天和第25 - 28天,加合物的积累速率为157 fmol加合物/微克DNA。此外,当两组再喂养28天对照饮食时,在这三天期间形成的加合物的清除速率相似。持续给予AAF导致持久性加合物缓慢积累;因此,在AAF喂养3天后检测到的加合物中,91±6%在随后一个月的对照饮食期间被清除,而当大鼠再喂养28天对照饮食时,在AAF饮食28天后检测到的加合物中只有65±11%被清除。在第二个实验中,比较了先前喂养含0.02% AAF饲料17天的动物在喂养对照或AAF饮食后加合物的清除情况。两组观察到相似的清除曲线;因此,持续摄入AAF并不影响加合物的清除速率。在两个实验中,均观察到双相修复曲线。这些数据被用于建立一个药代动力学模型。假定有两个基因组区域,一个易快速修复的区域和一个对AAF加合物清除更具抗性的区域。在AAF喂养2 - 3周后达到平衡时,每个区域的加合物浓度相似,约为150 fmol加合物/微克DNA。尽管在AAF给药一个月期间,快速修复区域形成的加合物总数比抗性区域大五倍,但该模型预测,在对照饮食一个月后检测到的持久性加合物位于对修复有抗性的区域。总体而言,慢性AAF喂养期间形成的加合物的清除非常有效,因为在随后一个月的对照饮食结束时,超过93%的加合物被清除。